PribitkinEAGrecoTMGoodeRLKeaneWM. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection. Arch Otolaryngol Head Neck Surg1997;123: 321–6.
2.
PierrardGELapiereCM. The microanatomical basis of facial frown lines. Arch Dermatol1989;125: 1090–2.
3.
KeenMBlitzerAAvivJBinderWPrystowskyJSmithHBotulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study. Plast Reconstr Surg1994;94:94–9.
4.
VinasJCCaviglaCCortinasJL. Forehead rhytidoplasty and brow lifting. Plast Reconstr Surg1976;57: 445–54.
VecchioneTR. Glabellar frown lines: Direct excision, an evaluation of the scars. Plast Reconstr Surg1990;86: 46–52.
7.
KobayashiT. Microsurgical treatment of nasolabial and glabellar wrinkles. J Dermatol Surg Oncol1992;18: 31–7.
8.
PollackS V. Silicone, fibril, and collagen implantation for facial lines and wrinkles. J Dermatol Surg Oncol1990;16: 957–61.
9.
NicolleF VMattiBAScampT. Dermal and facial autografts in facial aesthetic surgery. Aesthetic Plast Surg1992;16: 219–25.
10.
MoleB. The use of Gore-Tex implants in aesthetic surgery of the face. Plast Reconstr Surg1992;90: 200–6.
11.
BlitzerABrinMFKeenMSAvivJ. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg1993;119: 1018–22.
12.
Product information. Botox (botulinum toxin type A). Irvine, CA: Allergan, Inc., September 1995.
13.
LoweNJMaxwellAHarperH. Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol1996;35: 569–72.
14.
CarruthersJDAStubbsHA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entrophin. Can J Neurol Sci1987;14: 42–5.
15.
TsoyEABuckleyEGDuttonJJ. Treatment of blepharospasm with botulinum toxin. Am J Ophthalmol1985;99: 176–9.
16.
ScottABKennedyRAStubbsHA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol1985;103: 347–50.
17.
MaurielloJA. Blepharospasm, Meige's syndrome, and hemifacial spasm: Treatment with botulinum toxin. Neurology1985;35: 1499–500.
